PALIPALISADE BIO, INC.

Nasdaq palisadebio.com


$ 5.98 $ 0.13 (2.15 %)    

Monday, 29-Apr-2024 15:46:24 EDT
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 6.18
$ 6.34
$ 6.18 x 100
$ 0.00 x 0
$ 5.98 - $ 6.47
$ 3.82 - $ 36.60
217,635
na
2.82M
$ 0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-22-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-23-2021 06-30-2021 10-Q
12 05-14-2021 03-31-2021 10-Q
13 03-22-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-22-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-13-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-23-2017 12-31-2016 10-K
30 11-08-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-09-2016 03-31-2016 10-Q
33 03-14-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-08-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-08-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-palisade-bio-stock-is-up-today

Palisade Bio entered into a collaboration with Strand Life Sciences is aimed at advancing precision medicine for ulcerative col...

 sp-500-edges-lower-pacbio-shares-plunge

U.S. stocks traded mixed toward the end of trading, with the S&P 500 falling around 0.3% on Tuesday. The Dow traded up 0.0...

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 maxim-group-maintains-buy-on-palisade-bio-adjusts-price-target-to-225-reverse-stock-split-115

Maxim Group analyst Naz Rahman maintains Palisade Bio (NASDAQ:PALI) with a Buy, adjusts target to $22.5 from $22.5 (reverse ...

 gold-moves-higher-morgan-stanley-earnings-top-views

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0...

 why-palisade-bio-stock-is-soaring-today

Palisade Bio shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bi...

 palisade-bio-shares-resume-trade
Palisade Bio Shares Resume Trade
04/16/2024 13:49:09

 dow-gains-over-100-points-bank-of-america-posts-upbeat-profit

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market ...

 palisade-bio-presents-development-overview-of-pali-2108-at-the-ibd-innovate-product-development-for-crohns--colitis-april-9-10-2024-in-cambridge-ma

– PALI-2108 in development for the treatment of moderate-to-severe ulcerative colitis (UC) advancing towards Phase 1 clinical s...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION